NICE recommends NHS use of innovative treatment for severe blood disorder
2020-11-18T09:33:00
Patients suffering from a rare blood disorder may soon have a brand-new treatment after NICE recommended caplacizumab, with plasma exchange and immunosuppression for routine use on the NHS